Skip NavigationSkip to Content

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody

  1. Author:
    Richardson, Simone I [ORCID]
    Lambson, Bronwen E
    Crowley, Andrew R [ORCID]
    Bashirova,Arman
    Scheepers, Cathrine [ORCID]
    Garrett, Nigel [ORCID]
    Abdool Karim, Salim [ORCID]
    Mkhize, Nonhlanhla N [ORCID]
    Carrington,Mary
    Ackerman, Margaret E [ORCID]
    Moore, Penny L [ORCID]
    Morris, Lynn [ORCID]
  2. Author Address

    Centre for HIV and STI 39;s, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa., Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa., Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire, United States of America., Ragon Institute of Massachusetts General Hospital, MIT, and Harvard University, Boston, Massachusetts, United States of America., Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Congella, KwaZulu-Natal, South Africa., Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa., Department of Epidemiology, Columbia University, New York, NY, United States of America.,
    1. Year: 2019
    2. Date: Dec 16
    3. Epub Date: 2019 12 16
  1. Journal: PLoS pathogens
    1. 15
    2. 12
    3. Pages: e1008064
  2. Type of Article: Article
  3. Article Number: e1008064
  4. ISSN: 1553-7366
  1. Abstract:

    Broadly neutralizing antibodies (bNAbs) protect against HIV infection in non-human primates and their efficacy may be enhanced through interaction with Fc receptors on immune cells. Antibody isotype is a modulator of this binding with the IgG3 subclass mediating potent Fc effector function and is associated with HIV vaccine efficacy and HIV control. BNAb functions are typically assessed independently of the constant region with which they are naturally expressed. To examine the role of natural isotype in the context of a bNAb lineage we studied CAP256, an HIV-infected individual that mounted a potent V2-specific bNAb response. CAP256 expressed persistently high levels of plasma IgG3 which we found mediated both broad neutralizing activity and potent Fc function. Sequencing of germline DNA and the constant regions of V2-directed bNAbs from this donor revealed the expression of a novel IGHG3 allele as well as IGHG3*17, an allele that produces IgG3 antibodies with increased plasma half-life. Both allelic variants were used to generate CAP256-VRC26.25 and CAP256-VRC26.29 IgG3 bNAbs and these were compared to IgG1 versions. IgG3 variants were shown to have significantly higher phagocytosis and trogocytosis compared to IgG1 versions, which corresponded to increased affinity for Fc gamma RIIa. Neutralization potency was also significantly higher for IgG3 bNAbs, particularly against viruses lacking the N160 glycan. By exchanging hinge regions between subclass variants, we showed that hinge length modulated both neutralization potency and Fc function. This study showed that co-operation between the variable and natural IgG3 constant regions enhanced the polyfunctionality of antibodies, indicating the value of leveraging genetic variation which could be exploited for passive immunity. Author summary In the only partially effective HIV vaccine trial to date, reduced risk of infection correlated with IgG3 antibodies that bound to the V2 region of the HIV envelope. IgG3 antibodies potently mediate the broadest range of Fc cytotoxic functions such as complement deposition, cellular lysis, engulfment and membrane nibbling. The relevance of different IgG3 alleles in antibody function is not typically examined, nor are antibodies usually assessed in the context of their natural isotype. Here we show that IgG3 V2-specific broadly neutralizing antibodies from donor CAP256 mediated both enhanced cytotoxic functions and neutralization potency compared to an IgG1 variant. We demonstrate that the long hinge region of IgG3 facilitated this increased functionality. These data suggest that isotype may be tuned to enhance both neutralization and cytotoxic activity of broadly neutralizing antibodies that can be used to improve the efficacy of passive immunization strategies for HIV prevention.

    See More

External Sources

  1. DOI: 10.1371/journal.ppat.1008064
  2. PMID: 31841557
  3. WOS: 000507327900016
  4. PII : PPATHOGENS-D-19-01156

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel